Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are expecting strong performance driven by the continued https://fanniexxfd221398.dgbloggers.com/37170178/eli-lilly-stock-a-deep-dive-into-q3-earnings